Pfizer PE Ratio 2006-2018 | PFE

Current and historical p/e ratio for Pfizer (PFE) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pfizer PE ratio as of November 12, 2018 is 14.86.
Pfizer PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-11-12 44.11 11.17
2018-09-30 44.07 $3.95 11.16
2018-06-30 35.97 $3.73 9.64
2018-03-31 34.85 $3.59 9.71
2017-12-31 35.24 $3.51 10.04
2017-09-30 34.42 $1.62 21.25
2017-06-30 32.08 $1.36 23.59
2017-03-31 32.36 $1.18 27.42
2016-12-31 30.41 $1.16 26.22
2016-09-30 31.40 $1.13 27.79
2016-06-30 32.37 $1.26 25.69
2016-03-31 27.00 $1.35 20.00
2015-12-31 29.11 $1.24 23.48
2015-09-30 28.10 $1.33 21.13
2015-06-30 29.76 $1.41 21.11
2015-03-31 30.62 $1.44 21.27
2014-12-31 27.18 $1.42 19.14
2014-09-30 25.58 $1.62 15.79
2014-06-30 25.45 $1.59 16.01
2014-03-31 27.30 $3.12 8.75
2013-12-31 25.81 $3.14 8.22
2013-09-30 24.02 $3.60 6.67
2013-06-30 23.23 $3.64 6.38
2013-03-31 23.74 $2.09 11.36
2012-12-31 20.45 $1.95 10.49
2012-09-30 20.08 $1.29 15.57
2012-06-30 18.42 $1.34 13.74
2012-03-31 17.96 $1.24 14.48
2011-12-31 16.98 $1.28 13.27
2011-09-30 13.74 $1.45 9.48
2011-06-30 15.83 $1.08 14.66
2011-03-31 15.46 $1.06 14.59
2010-12-31 13.19 $1.03 12.81
2010-09-30 12.80 $0.77 16.62
2010-06-30 10.52 $1.09 9.65
2010-03-31 12.52 $1.12 11.18
2009-12-31 13.15 $1.27 10.35
2009-09-30 11.85 $1.21 9.79
2009-06-30 10.63 $1.12 9.49
2009-03-31 9.55 $1.19 8.02
2008-12-31 12.15 $1.20 10.12
2008-09-30 12.41 $1.58 7.86
2008-06-30 11.57 $1.35 8.57
2008-03-31 13.64 $1.12 12.18
2007-12-31 14.61 $1.19 12.28
2007-09-30 15.51 $2.09 7.42
2007-06-30 16.04 $2.44 6.57
2007-03-31 15.68 $2.59 6.05
2006-12-31 15.90 $2.67 5.96
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $263.593B $52.546B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $389.933B 18.28
Novartis AG (NVS) Switzerland $206.763B 17.67
Merck (MRK) United States $201.837B 17.49
AbbVie (ABBV) United States $133.559B 11.85
Eli Lilly (LLY) United States $118.867B 20.90
Sanofi (SNY) France $114.344B 14.16
Novo Nordisk (NVO) Denmark $109.812B 17.83
AstraZeneca (AZN) United Kingdom $103.773B 12.88
GlaxoSmithKline (GSK) United Kingdom $102.421B 13.77
Bristol-Myers Squibb (BMY) United States $87.143B 14.35